Participants 242 277 7
patients with head-and-neck cancer.
Participants 300 551 5
Fifty patients were randomized to receive conventional radiotherapy (RT) (2-Gy fractions, 5 days weekly, to a total of 60-74 Gy, depending on the tumor localization and TNM classification) and carboplatin (90 mg/m(2) infusion once per week before RT).
Participants 2101 2135 3
patients with head-and-neck cancer
